PRODUCT PROCESS CONTROL ISSUE

This adverse event was reported 12 times

PRODUCT PROCESS CONTROL ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 3% SODIUM CHLORIDE 1 0.0088
1 I. V. FAT EMULSION 3 0.0041
2 CLASCOTERONE 1 0.0007
3 SODIUM CHLORIDE 0.65% 1 0.0007
4 ENSIFENTRINE 1 0.0005
5 TAMOXIFEN CITRATE 1 0.0002
6 MESNA 1 0.0001
7 FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE 1 0.0000
8 ISOTRETINOIN 1 0.0000
9 0XYGEN 1 0.0000
See all drugs enriched for association with PRODUCT PROCESS CONTROL ISSUE

PRODUCT PROCESS CONTROL ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lipid Emulsion [EPC] 3 0.0011
1 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
2 Androgen Receptor Inhibitor [EPC] 1 0.0000
3 Interleukin-12 Antagonist [EPC] 1 0.0000
4 Interleukin-23 Antagonist [EPC] 1 0.0000
5 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
6 Estrogen [EPC] 1 0.0000
7 Retinoid [EPC] 1 0.0000
8 Osmotic Laxative [EPC] 1 0.0000
See all drug classes enriched for association with PRODUCT PROCESS CONTROL ISSUE